Careers  |  Sign In  |  Register  |   Twitter

FDA Approves Once-Daily Pill for HIV

“U.S. health regulators on Monday approved Gilead Sciences Inc’s four-drug combination pill to treat HIV…”

“Stribild, a once-daily treatment, contains two previously approved HIV medicines and two new drugs. The older medicines, emtricitabine and tenofovir, are currently sold by Gilead in its combination pill Truvada, which was approved in 2004, and are also part of Gilead’s Atripla three-drug combination. The newer drugs are elvitegravir and cobicistat.”

Read it in Reuters.